Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV

• Main Authors: Lerato Mohapi, Yvett Pinedo, Olayemi Osiyemi, Khuanchai Supparatpinyo, Winai Ratanasuwan, Jean Michel Molina, Ron Dagan, Gretchen Tamms, Tina Sterling, Ying Zhang, Alison Pedley, Jon Hartzel, Yanqing Kan, Kim Hurtado, Luwy Musey, Jakub K. Simon, Ulrike K. Buchwald
• Other Authors: Siriraj Hospital
• Format: Article
• Published: 2022
• Subjects: Immunology and Microbiology; Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/74152
• Institution: Mahidol University

Objectives: To evaluate safety and immunogenicity of V114 [15-valent pneumococcal conjugate vaccine (PCV) containing serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, and 33F], followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23) 8 weeks later, in adults living with HI...